Merck agrees to acquire $1bn equity stake in Seattle Genetics
Merck will make an upfront payment of $600m along with a $1bn equity investment by acquiring five million…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Sep 20
Merck will make an upfront payment of $600m along with a $1bn equity investment by acquiring five million…
02 Sep 20
JTX-1811 is a monoclonal antibody, designed to selectively target immunosuppressive tumor-infiltrating T regulatory (TITR) cells
26 Aug 20
Sinovac will provide Bio Farma with bulk vaccine, enabling it manufacture a minimum of 40 million doses of…
19 Aug 20
Both Lilly and Innovent have been studying Tyvyt to treat non-squamous non-small cell lung cancer (NSCLC) and various…
17 Aug 20
The current supply agreement follows AstraZeneca’s previous agreement with Inclusive Vaccines Alliance (IVA) to supply 400 million doses…
14 Aug 20
UNION has agreed to pay up to $210m to TFF Pharmaceuticals, to support the development, regulatory approvals and…
07 Aug 20
The licence agreement allows SIIPL to supply the potential Covid-19 vaccine only in low- and middle-income countries (LMIC)…
27 Jul 20
The collaboration is aimed at developing and commercialising DS-1062, around the world, except in Japan, where Daiichi Sankyo…
20 Jul 20
GSK will pay $131m upfront in cash and make one-time reimbursable payment of $32.8m to reserve the manufacturing…
15 Jul 20
Roche will pay $675m in upfront cash and $100m in equity investment in Blueprint Medicines, along with up…